| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.6 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.6 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.6 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.6 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.02 | 0.6 |